← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1990Last known activity
Jan 1, 2018
Timeline
1990s
- Jan 1, 1990
National Center for Research Resources (NCRR)— Founded
Drugs by trial phase (281 distinct, 287 trials)
Phase 4 (32 own, 0 via acquisition)
Phase 3 (48 own, 0 via acquisition)
Phase 2 (113 own, 0 via acquisition)
Phase 1 (25 own, 0 via acquisition)
Other trials (63 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acanthosis Nigricans
- Acquired Immunodeficiency Syndrome
- Acute Lung Injury
- Addison Disease
- Adrenal Hyperplasia, Congenital
- Adrenal Insufficiency
- Adrenocortical Hyperfunction
- Adrenogenital Syndrome
- Alcohol Drinking
- Alcoholism
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Amenorrhea
- Amino Acid Metabolism, Inborn Errors
- Amyotrophic Lateral Sclerosis
- Anemia
- Anemia, Aplastic
- Anemia, Neonatal
- Anemia, Sickle Cell
- Anorexia
- Anorexia Nervosa
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Atrophy
- Bacterial Infections
- Bacteriuria
- Berylliosis
- Biliary Dyskinesia
- Birth Weight
- Blastomycosis
- Body Weight
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Bulbo-Spinal Atrophy, X-Linked
- Calcinosis
- Calculi
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Renal Cell
- Cardiomyopathies
- Central Nervous System Diseases
- Cerebral Hemorrhage
- Cholangitis
- Cholangitis, Sclerosing
- Cholestasis
- Chronic Kidney Disease-Mineral and Bone Disorder
- Churg-Strauss Syndrome
- Cognitive Dysfunction
- Colitis
- Colitis, Lymphocytic
- Colitis, Ulcerative
- Communicable Diseases
- Compulsive Personality Disorder
- Constipation
- Constriction, Pathologic
- Crohn Disease
- Cystic Fibrosis
- Cysts
- Cytomegalovirus Infections
- Cytomegalovirus Retinitis
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetes Mellitus
- Diabetes Mellitus, Experimental
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Diarrhea
- Digestive System Diseases
- Dilatation, Pathologic
- Disease
- Ductus Arteriosus, Patent
- Dyskeratosis Congenita
- Dyskinesias
- Epidermolysis Bullosa
- Epidermolysis Bullosa Acquisita
- Epilepsy
- Eye Diseases
- Familial Primary Pulmonary Hypertension
- Fanconi Anemia
- Fanconi Syndrome
- Fecal Incontinence
- Fibrosis
- Gastrointestinal Diseases
- Gastroparesis
- Gaucher Disease
- Gingivitis
- Glucose Intolerance
- Graves Ophthalmopathy
- Heart Diseases
- Heart Failure
- Hemophilia B
- Hemorrhage
Recent trials (50)
- NCT03350906CollaboratorPhase 3Jan 1, 2018
- NCT02215200CollaboratorPhase 2Dec 1, 2014
- NCT02203630CollaboratorPhase 4Aug 1, 2014
- NCT02232308CollaboratorPhase 1Jul 1, 2014
- NCT01954056CollaboratorPhase 3Jul 1, 2014
- NCT02128581CollaboratorPhase 1May 1, 2014
- NCT02195115CollaboratorPhase 2Feb 1, 2014
- NCT02049203CollaboratorPhase 1Jan 1, 2014
- NCT01783821CollaboratorPhase 2Jul 1, 2013
- NCT01832532CollaboratorPhase 1/Phase 2Apr 1, 2013
- NCT01669538CollaboratorPhase 2Aug 1, 2012
- NCT01726088CollaboratorPhase 2/Phase 3Aug 1, 2012
- NCT01772537CollaboratorN/AMay 1, 2012
- NCT01843881CollaboratorEarly Phase 1Mar 1, 2012
- NCT01544998CollaboratorPhase 1/Phase 2Feb 1, 2012
Details
- Founded
- Bethesda, MD, US Jan 1, 1990
- Last known activity
- Jan 1, 2018
Notes
NCRR was abolished in December 2011 as part of an NIH reorganization to create the National Center for Advancing Translational Sciences (NCATS). Several of NCRR's programs were reassigned to other NIH institutes and centers.